Highline Sciences Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Highline Sciences's estimated annual revenue is currently $2.8M per year.(i)
  • Highline Sciences's estimated revenue per employee is $155,000

Employee Data

  • Highline Sciences has 18 Employees.(i)
  • Highline Sciences grew their employee count by -14% last year.

Highline Sciences's People

NameTitleEmail/Phone
1
Clinical Systems OwnerReveal Email/Phone
2
Clinical Project ManagerReveal Email/Phone
3
Administrative ManagerReveal Email/Phone
4
Sr. Manager, Regulatory OperationsReveal Email/Phone
5
Associate Project ManagerReveal Email/Phone
6
Clinical Trial LeadReveal Email/Phone
7
Sr. Associate, Regulatory & Investigator Services, Tempus Labs (formerly Highline Sciences)Reveal Email/Phone
8
Lead Clinical Research AssociateReveal Email/Phone
9
Sr. Clinical Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Highline Sciences?

Highline Sciences provides life science companies with custom clinical research and commercial marketing consulting services. What sets us apart is our laser focus on talent. It’s all about the team. We know that our success and the success of our clients is dependent on our ability to deploy the best teams in the business. We get to know our clients thoroughly and work closely with them to design the teams and services that are tailored to their specific needs, all the way from strategic clinical development consulting to full-service CRO solutions.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M18-14%$69.1M
#2
$1.7M18-14%N/A
#3
$1.6M18-31%N/A
#4
$0.8M18-10%$3M
#5
$0.5M18-10%N/A